Literature DB >> 21488890

T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells.

Guoyan Cheng1, Aixin Yu, Thomas R Malek.   

Abstract

Signaling through the interleukin-2 receptor (IL-2R) contributes to T-cell tolerance by controlling three important aspects of regulatory T-cell (Treg) biology. IL-2 is essential for thymic Treg development and regulates Treg homeostasis and suppressive function. Analogous to activated conventional T lymphocytes, IL-2R signaling also plays an important part in Treg cell growth, survival, and effector differentiation. However, Treg cells somewhat distinctively assimilate IL-2R signaling. In particular, Treg cells require essentially only IL-2-dependent receptor proximal signal transducer and activator of transcription 5 (Stat5) activation, as they contain inhibitory pathways to minimize IL-2R-dependent activation of the phosphatidyinositol 3-kinase/Akt pathway. Moreover, many IL-2R-dependent activities, including full induction of Foxp3 expression, in Treg cells require minimal and transient Stat5 activation. Thus, Treg cells are equipped to sense and then develop and function within biological niches containing minimal IL-2. These distinguishing features of IL-2R signaling provide a mechanistic underpinning for using IL-2 as an agent to selectively target Treg cells in immunotherapy to induce tolerance in autoimmune diseases and in allogeneic transplant recipients.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21488890      PMCID: PMC3101713          DOI: 10.1111/j.1600-065X.2011.01004.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  111 in total

1.  Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo.

Authors:  Marc A Gavin; Sally R Clarke; Ella Negrou; Alena Gallegos; Alexander Rudensky
Journal:  Nat Immunol       Date:  2001-12-10       Impact factor: 25.606

2.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.

Authors:  Rebecca S McHugh; Matthew J Whitters; Ciriaco A Piccirillo; Deborah A Young; Ethan M Shevach; Mary Collins; Michael C Byrne
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

3.  Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms.

Authors:  M Wolf; A Schimpl; T Hünig
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

Review 4.  Signaling domains of the interleukin 2 receptor.

Authors:  S L Gaffen
Journal:  Cytokine       Date:  2001-04-21       Impact factor: 3.861

5.  Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors.

Authors:  T R Malek; B O Porter; E K Codias; P Scibelli; A Yu
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

6.  JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.

Authors:  B Sporri; P E Kovanen; A Sasaki; A Yoshimura; W J Leonard
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

7.  Shedding light on sheddases: role in growth and development.

Authors:  Farrah Kheradmand; Zena Werb
Journal:  Bioessays       Date:  2002-01       Impact factor: 4.345

8.  Allelic expression and interleukin-2 polymorphisms in multiple sclerosis.

Authors:  F Matesanz; M Fedetz; M Collado-Romero; O Fernández; M Guerrero; C Delgado; A Alcina
Journal:  J Neuroimmunol       Date:  2001-09-03       Impact factor: 3.478

9.  The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements.

Authors:  H P Kim; J Kelly; W J Leonard
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

10.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  102 in total

1.  Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study.

Authors:  Yamin Tan; Haowen Xiao; Depei Wu; Yi Luo; Jianping Lan; Qifa Liu; Kang Yu; Jimin Shi; Jingsong He; Weiyan Zheng; Xiaoyu Lai; Yuanyuan Zhu; Kaili Du; Yishan Ye; Yanmin Zhao; Gaofeng Zheng; Yongxian Hu; Xiaoyan Han; Yanlong Zheng; Guoqing Wei; Zhen Cai; He Huang
Journal:  Oncoimmunology       Date:  2017-01-06       Impact factor: 8.110

Review 2.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

3.  Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors.

Authors:  Nicolas Thiault; Julie Darrigues; Véronique Adoue; Marine Gros; Bénédicte Binet; Corine Perals; Bertrand Leobon; Nicolas Fazilleau; Olivier P Joffre; Ellen A Robey; Joost P M van Meerwijk; Paola Romagnoli
Journal:  Nat Immunol       Date:  2015-05-04       Impact factor: 25.606

4.  Interleukin-2-mediated inhibition of dendritic cell development correlates with decreased CD135 expression and increased monocyte/macrophage precursors.

Authors:  Alan D Guerrero; Matthew B Dong; Yongge Zhao; Annie Lau-Kilby; Kristin V Tarbell
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

Review 5.  Targeted immune interventions for type 1 diabetes: not as easy as it looks!

Authors:  Mark R Rigby; Mario R Ehlers
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-08       Impact factor: 3.243

Review 6.  T cells in the control of organ-specific autoimmunity.

Authors:  Jeffrey A Bluestone; Hélène Bour-Jordan; Mickie Cheng; Mark Anderson
Journal:  J Clin Invest       Date:  2015-05-18       Impact factor: 14.808

7.  Murein lytic enzyme TgaA of Bifidobacterium bifidum MIMBb75 modulates dendritic cell maturation through its cysteine- and histidine-dependent amidohydrolase/peptidase (CHAP) amidase domain.

Authors:  Simone Guglielmetti; Ivan Zanoni; Silvia Balzaretti; Matteo Miriani; Valentina Taverniti; Ivano De Noni; Ilaria Presti; Milda Stuknyte; Alessio Scarafoni; Stefania Arioli; Stefania Iametti; Francesco Bonomi; Diego Mora; Matti Karp; Francesca Granucci
Journal:  Appl Environ Microbiol       Date:  2014-05-09       Impact factor: 4.792

8.  High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion.

Authors:  Samuel Amoah; Beth C Holbrook; Rama D Yammani; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

Review 9.  Induced regulatory T cells in inhibitory microenvironments created by cancer.

Authors:  Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2014-06-17       Impact factor: 4.388

10.  GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways.

Authors:  Nirjal Bhattarai; James H McLinden; Jinhua Xiang; Thomas M Kaufman; Jack T Stapleton
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.